Michael Kean: Complementary Strategies
Michael Kean's journey demonstrates that successful trading is not just about finding profitable opportunities—it is about constructing a portfolio that can perform consistently across different market conditions. Unlike many traders who depend on a single strategy or market direction, Kean built his success by combining multiple approaches that complement one another. His philosophy is based on the idea that different strategies should work together to reduce overall portfolio risk while still allowing attractive returns.
Kean's career began as a personal interest while he was a university student in New Zealand. What started as a hobby eventually developed into a professional investment career, where he consistently generated returns that significantly outperformed the broader market while maintaining relatively modest drawdowns. His performance highlights an important principle: exceptional investing is not measured solely by how much money is made, but also by how effectively risk is controlled along the way.
One of the most interesting aspects of Kean's approach is that some of his most valuable risk-management tools appear risky at first glance. For example, he frequently uses short positions in biotechnology companies around important clinical trial announcements or after major overnight price gaps caused by corporate news. These trades might seem dangerous to inexperienced investors because of their volatility, but Kean incorporates them into a carefully designed portfolio where they serve a specific purpose. Rather than chasing excitement, he uses these positions to balance the overall behavior of his investments.
Kean believes that effective risk management operates on multiple levels. The first level concerns individual trades. Every position should have a clearly defined maximum acceptable loss before the trade is entered. Limiting losses on individual positions prevents a single mistake from causing significant damage to the overall portfolio.
The second level involves managing the portfolio as a whole. Even if every individual trade has controlled risk, the portfolio can still become vulnerable if many positions respond similarly to changing market conditions. Holding several investments that all move in the same direction may create hidden exposure that only becomes obvious during periods of market stress. Kean therefore pays close attention not only to individual trades but also to how those trades interact with one another.
Correlation plays a central role in his investment philosophy. Many investors unknowingly build portfolios where nearly every position depends on the same market forces. During strong bull markets this may produce impressive returns, but during market declines almost every investment falls simultaneously. Kean addresses this weakness by deliberately combining positions that behave differently under various market conditions. Ideally, some investments should remain uncorrelated, while others should move in the opposite direction. This balance allows gains in one area to partially offset losses elsewhere, reducing overall volatility without sacrificing long-term performance.
The structure of Kean's portfolio reflects this thinking. A significant portion consists of long-term equity investments that benefit from the overall growth of the stock market. Alongside these holdings, he maintains a separate trading portfolio composed primarily of short-term trades and selective short positions, particularly within biotechnology stocks. These positions often move independently of his long-term investments and, in many cases, perform well when the broader market experiences weakness. By combining these different components, Kean creates a portfolio that is more resilient than a traditional long-only investment strategy.
Importantly, Kean emphasizes that readers should not attempt to copy his exact portfolio structure. His methods require specialized knowledge, particularly in biotechnology, where understanding clinical trial data and industry developments is essential. Instead, the broader lesson is that every investor should think beyond individual stock selection and consider how different investments work together. Diversification becomes truly effective only when the components of a portfolio respond differently to changing market conditions.
Risk management also influences the size of every trade Kean places. Early in his career, he experienced one of his largest losses after shorting a rapidly rising stock without a well-defined contingency plan. As the price continued climbing, the position inflicted a significant loss on his portfolio. Rather than viewing the experience as bad luck, Kean accepted responsibility and permanently changed his trading process. From that point onward, every trade included carefully defined risk limits. The painful lesson reinforced his belief that preserving capital is far more important than proving a market opinion correct.
His position-sizing rules also reflect this disciplined mindset. For biotechnology trades, where he possesses deep expertise, Kean is willing to accept slightly higher risk because he understands the industry thoroughly. For sectors outside his primary area of knowledge, he limits risk much more aggressively. This distinction highlights another important principle: conviction should be based on competence. Traders should allocate larger amounts of capital only in areas where they possess genuine understanding rather than equal confidence across every opportunity.
Another valuable lesson comes from a period when success temporarily weakened his discipline. After producing exceptional gains during one year, Kean began believing he could take additional risks simply because he had accumulated a substantial profit cushion. Acting outside his established methodology, he purchased several energy stocks that appeared inexpensive after a sharp decline. The decision was driven more by optimism than by his proven investment process. Within just a few weeks, a significant portion of his annual profits disappeared. The experience reminded him that previous success never justifies abandoning established rules.
This episode illustrates a common psychological challenge faced by many traders. Success can be just as dangerous as failure if it creates overconfidence. Profitable periods often encourage investors to believe they possess exceptional insight, tempting them to ignore the very rules responsible for their success. Kean learned that discipline must remain consistent regardless of recent performance. Markets do not reward confidence alone; they reward disciplined execution of a repeatable process.
Another recurring theme throughout the chapter is the importance of continuous learning. Kean never assumes that his methods are perfect. Instead, he regularly reviews mistakes, evaluates decisions, and refines his approach. Trading is presented as an ongoing educational process rather than a destination. Every success reinforces good habits, while every mistake provides valuable information for future improvement.
Ultimately, Michael Kean's story demonstrates that superior investing is built upon balance. A strong portfolio is not created by chasing the highest possible returns but by combining complementary strategies that work together across changing market environments. His experience reinforces that successful investors think beyond individual trades, focusing instead on how every position contributes to the overall health of the portfolio. Through careful diversification, disciplined risk management, thoughtful position sizing, and unwavering commitment to continuous improvement, Kean shows that long-term consistency is often a greater achievement than short-term brilliance.